P2.01-01 Initial Result of the ImmunoPET Phase1 Study: Characterising PD-L1 During Chemoradiotherapy with 89Zr- Durvalumab (MEDI4736) PET/CT

Saved in:

Bibliographic Details
Published in	Journal of thoracic oncology Vol. 18; no. 11; p. S295
Main Authors	Hegi-Johnson, F., Rudd, S., Roselt, P., Wichmann, C., Sursock, S., Akhurst, T., Jackson, P., Hicks, R., Scott, A., Donnelly, P., John, T., MacManus, M.
Format	Journal Article
Language	English
Published	01.11.2023
Online Access	Get full text

Loading…

More Information
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2023.09.506